287 related articles for article (PubMed ID: 19763089)
1. NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain.
Laplantine E; Fontan E; Chiaravalli J; Lopez T; Lakisic G; Véron M; Agou F; Israël A
EMBO J; 2009 Oct; 28(19):2885-95. PubMed ID: 19763089
[TBL] [Abstract][Full Text] [Related]
2. Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome.
Ngadjeua F; Chiaravalli J; Traincard F; Raynal B; Fontan E; Agou F
J Biol Chem; 2013 Nov; 288(47):33722-33737. PubMed ID: 24100029
[TBL] [Abstract][Full Text] [Related]
3. Covalent modification of the NF-κB essential modulator (NEMO) by a chemical compound can regulate its ubiquitin binding properties in vitro.
Hooper C; Jackson SS; Coughlin EE; Coon JJ; Miyamoto S
J Biol Chem; 2014 Nov; 289(48):33161-74. PubMed ID: 25296760
[TBL] [Abstract][Full Text] [Related]
4. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
[TBL] [Abstract][Full Text] [Related]
5. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
6. Mechanism underlying IκB kinase activation mediated by the linear ubiquitin chain assembly complex.
Fujita H; Rahighi S; Akita M; Kato R; Sasaki Y; Wakatsuki S; Iwai K
Mol Cell Biol; 2014 Apr; 34(7):1322-35. PubMed ID: 24469399
[TBL] [Abstract][Full Text] [Related]
7. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB.
Du M; Ea CK; Fang Y; Chen ZJ
Mol Cell; 2022 Jul; 82(13):2415-2426.e5. PubMed ID: 35477005
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin.
Yoshikawa A; Sato Y; Yamashita M; Mimura H; Yamagata A; Fukai S
FEBS Lett; 2009 Oct; 583(20):3317-22. PubMed ID: 19766637
[TBL] [Abstract][Full Text] [Related]
9. NF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activation.
Hadian K; Griesbach RA; Dornauer S; Wanger TM; Nagel D; Metlitzky M; Beisker W; Schmidt-Supprian M; Krappmann D
J Biol Chem; 2011 Jul; 286(29):26107-17. PubMed ID: 21622571
[TBL] [Abstract][Full Text] [Related]
10. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121
[TBL] [Abstract][Full Text] [Related]
11. Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB.
Kensche T; Tokunaga F; Ikeda F; Goto E; Iwai K; Dikic I
J Biol Chem; 2012 Jul; 287(28):23626-34. PubMed ID: 22605335
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
[TBL] [Abstract][Full Text] [Related]
13. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains.
Emmerich CH; Ordureau A; Strickson S; Arthur JS; Pedrioli PG; Komander D; Cohen P
Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15247-52. PubMed ID: 23986494
[TBL] [Abstract][Full Text] [Related]
14. Evidence for M1-Linked Polyubiquitin-Mediated Conformational Change in NEMO.
Hauenstein AV; Xu G; Kabaleeswaran V; Wu H
J Mol Biol; 2017 Dec; 429(24):3793-3800. PubMed ID: 29111346
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
Gautheron J; Pescatore A; Fusco F; Esposito E; Yamaoka S; Agou F; Ursini MV; Courtois G
Hum Mol Genet; 2010 Aug; 19(16):3138-49. PubMed ID: 20529958
[TBL] [Abstract][Full Text] [Related]
16. NEMO oligomerization and its ubiquitin-binding properties.
Ivins FJ; Montgomery MG; Smith SJ; Morris-Davies AC; Taylor IA; Rittinger K
Biochem J; 2009 Jun; 421(2):243-51. PubMed ID: 19422324
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase.
Windheim M; Stafford M; Peggie M; Cohen P
Mol Cell Biol; 2008 Mar; 28(5):1783-91. PubMed ID: 18180283
[TBL] [Abstract][Full Text] [Related]
18. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.
Zhu G; Wu CJ; Zhao Y; Ashwell JD
Curr Biol; 2007 Aug; 17(16):1438-43. PubMed ID: 17702576
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for recognition of diubiquitins by NEMO.
Lo YC; Lin SC; Rospigliosi CC; Conze DB; Wu CJ; Ashwell JD; Eliezer D; Wu H
Mol Cell; 2009 Mar; 33(5):602-15. PubMed ID: 19185524
[TBL] [Abstract][Full Text] [Related]
20. New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein.
Hubeau M; Ngadjeua F; Puel A; Israel L; Feinberg J; Chrabieh M; Belani K; Bodemer C; Fabre I; Plebani A; Boisson-Dupuis S; Picard C; Fischer A; Israel A; Abel L; Veron M; Casanova JL; Agou F; Bustamante J
Blood; 2011 Jul; 118(4):926-35. PubMed ID: 21622647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
